{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:04:01Z","timestamp":1790744641598,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["IF200135"],"award-info":[{"award-number":["IF200135"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bmc.2026.118704","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:31:13Z","timestamp":1778758273000},"page":"118704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of novel multifunctional caffeic acid-piperazine derivatives for the management of Alzheimer's disease"],"prefix":"10.1016","volume":"140","author":[{"given":"Sunil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairam","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyan","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118704_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117419","article-title":"Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer\u2019s disease","volume":"91","author":"Uliassi","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0010","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acschemneuro.8b00391","article-title":"Reconsideration of anticholinesterase therapeutic strategies against Alzheimer\u2019s disease","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118704_bb0015","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia, WHO."},{"key":"10.1016\/j.bmc.2026.118704_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/CON.0000000000000700","article-title":"Late-onset Alzheimer disease","volume":"25","author":"Rabinovici","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.bmc.2026.118704_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113947","article-title":"N-methylated diazabicyclo[3.2.2]nonane substituted triterpenoic acids are excellent, hyperbolic and selective inhibitors for butyrylcholinesterase","volume":"227","author":"Heise","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0030","unstructured":"https:\/\/www.alzint.org\/about\/dementia-facts-figures\/dementia-statistics\/, Alzheimer's Disease International."},{"key":"10.1016\/j.bmc.2026.118704_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118704_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118704_bb0045","series-title":"Novel multifunctional tacrine\u2013donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies","first-page":"2300575","volume":"357","author":"Bayraktar","year":"2024"},{"key":"10.1016\/j.bmc.2026.118704_bb0050","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1039\/D1MD00046B","article-title":"Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties","volume":"12","author":"de Andrade Ramos","year":"2021","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14283\/jpad.2018.43","article-title":"Revisiting the cholinergic hypothesis in Alzheimer\u2019s disease: emerging evidence from translational and clinical research","volume":"6","author":"Hampel","year":"2019","journal-title":"The journal of prevention of Alzheimer\u2019s disease"},{"key":"10.1016\/j.bmc.2026.118704_bb0060","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1021\/acs.jmedchem.5c00577","article-title":"Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer\u2019s Disease","volume":"68","author":"Ko\u0161ak","year":"2025","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2026.118704_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2012.12.054","article-title":"Butyrylcholinesterase and the cholinergic system","volume":"234","author":"Reid","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2026.118704_bb0070","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1021\/acs.jmedchem.4c01866","article-title":"Enhanced recognition memory through dual modulation of brain carbonic anhydrases and Cholinesterases","volume":"67","author":"Nocentini","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118704_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2026.118704_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112601","article-title":"The impact of chelating compounds on Cu2+, Fe2+\/3+, and Zn2+ ions in Alzheimer\u2019s disease treatment","volume":"257","author":"Mazur","year":"2024","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmc.2026.118704_bb0090","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cmdc.201600014","article-title":"Novel 8-Hydroxyquinoline derivatives as multitarget compounds for the treatment of Alzheimer\u2019s disease","volume":"11","author":"Prati","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118704_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112257","article-title":"Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer\u2019s disease","volume":"198","author":"Singh","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116385","article-title":"Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer\u2019s disease","volume":"46","author":"Singh","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0105","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/acschemneuro.3c00679","article-title":"Design, synthesis, and biological evaluation of Ferulic acid template-based novel multifunctional ligands targeting NLRP3 Inflammasome for the Management of Alzheimer\u2019s disease","volume":"15","author":"Singh","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118704_bb0110","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1021\/acschemneuro.4c00130","article-title":"Design, synthesis, and biological evaluation of Ferulic acid-Piperazine derivatives targeting pathological hallmarks of Alzheimer\u2019s disease","volume":"15","author":"Singh","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118704_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-68282-3","article-title":"Discovery of NIRF theranostic probes targeting amyloid-\u03b2 and cholinesterases in Alzheimer\u2019s disease models","volume":"17","author":"Rai","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2026.118704_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117831","article-title":"Design, synthesis, and biological evaluation of caffeic acid-based novel multifunctional molecules for the management of Alzheimer\u2019s disease","volume":"296","author":"Kumar","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117198","article-title":"Design, synthesis and biological evaluation of galantamine analogues for cognitive improvement in Alzheimer\u2019s disease","volume":"284","author":"Li","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117066","article-title":"Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer\u2019s disease","volume":"283","author":"Shankar","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111683","article-title":"Discovery of a new function of human butyrylcholinesterase and the catalytic activity of its natural variants toward homocysteine thiolactone hydrolysis","volume":"420","author":"Chen","year":"2025","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2026.118704_bb0140","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of highly selective and Nanomolar carbamate-based Butyrylcholinesterase inhibitors by rational investigation into their inhibition mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0145","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1021\/acs.jmedchem.4c00355","article-title":"Butyrylcholinesterase-activated near-infrared Fluorogenic probe for in vivo Theranostics of Alzheimer\u2019s disease","volume":"67","author":"Wang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0150","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2026.118704_bb0155","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1038\/s41598-018-22747-2","article-title":"Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118704_bb0160","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.apsb.2025.02.030","article-title":"Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer\u2019s disease","volume":"15","author":"Sang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2026.118704_bb0165","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2026.118704_bb0170","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","article-title":"Highly potent and selective Butyrylcholinesterase inhibitors for cognitive improvement and neuroprotection","volume":"64","author":"Li","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104974","article-title":"Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer\u2019s disease treatment","volume":"112","author":"Makhaeva","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106749","article-title":"Design and development of benzyl piperazine linked 5-phenyl-1,2,4-triazole-3-thione conjugates as potential agents to combat Alzheimer\u2019s disease","volume":"139","author":"Kiran","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0185","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.bmc.2014.05.029","article-title":"Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors","volume":"22","author":"Yin","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0190","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0319-23.2024","article-title":"Lecanemab and Donanemab as therapies for Alzheimer\u2019s disease: an illustrated perspective on the data","volume":"11","author":"Espay","year":"2024","journal-title":"eNeuro"},{"key":"10.1016\/j.bmc.2026.118704_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100068","article-title":"Use of Lecanemab and Donanemab in the Canadian healthcare system: evidence, challenges, and areas for future research","volume":"12","author":"Smith","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.bmc.2026.118704_bb0200","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1517\/13543784.9.10.2393","article-title":"Review of the acetylcholinesterase inhibitor galanthamine","volume":"9","author":"Sramek","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bmc.2026.118704_bb0205","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-\u03b2-peptides into Alzheimer\u2019s fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.bmc.2026.118704_bb0210","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejmech.2018.06.044","article-title":"Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer\u2019s disease","volume":"155","author":"Chioua","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"beta-amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2026.118704_bb0220","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2026.118704_bb0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41420-024-02278-8","article-title":"Free radicals and their impact on health and antioxidant defenses: a review","volume":"11","author":"Chandimali","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2026.118704_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.110801","article-title":"A rapid and simplified DPPH assay for analysis of antioxidant interactions in binary combinations","volume":"202","author":"Silva","year":"2024","journal-title":"Microchem J"},{"key":"10.1016\/j.bmc.2026.118704_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107373","article-title":"Synthesis and biological evaluation of halogen-substituted novel \u03b1-Ketoamides as potential protein aggregation modulators in Alzheimer\u2019s disease","volume":"147","author":"Das","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0240","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0245","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/acs.jpcb.7b02914","article-title":"Predicting a drug\u2019s membrane permeability: a computational model validated with in vitro permeability assay data","volume":"121","author":"Bennion","year":"2017","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.bmc.2026.118704_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117277","article-title":"Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer\u2019s disease","volume":"286","author":"Azam","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0255","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.3233\/JAD-240605","article-title":"Iron chelators and Alzheimer\u2019s disease clinical trials","volume":"100","author":"Mandal","year":"2024","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.bmc.2026.118704_bb0260","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40263-024-01093-0","article-title":"Targeting biometals in Alzheimer\u2019s disease with metal chelating agents including Coumarin derivatives","volume":"38","author":"Guck\u00fd","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bmc.2026.118704_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2021.126779","article-title":"Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer\u2019s disease: limitations, and current and future perspectives","volume":"67","author":"Fasae","year":"2021","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.bmc.2026.118704_bb0270","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2026.118704_bb0275","series-title":"The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics","first-page":"353","volume":"297","author":"Hardy","year":"2002"},{"key":"10.1016\/j.bmc.2026.118704_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116959","article-title":"Discovery of novel substituted (Z)-N\u2032-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer\u2019s disease","volume":"280","author":"Shankar","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118704_bb0285","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.bmc.2026.118704_bb0290","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr Biol"},{"key":"10.1016\/j.bmc.2026.118704_bb0295","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer's disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed Rep"},{"key":"10.1016\/j.bmc.2026.118704_bb0300","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bmc.2026.118704_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.bmc.2026.118704_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2024.112975","article-title":"Characterization, DFT study and evaluation of antioxidant potentials of mycosporine-like amino acids (MAAs) in the cyanobacterium Anabaenopsis circularis HKAR-22","volume":"257","author":"Singh","year":"2024","journal-title":"J Photochem Photobiol B Biol"},{"key":"10.1016\/j.bmc.2026.118704_bb0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/ct700248k","article-title":"Performance of B3LYP density functional methods for a large set of organic molecules","volume":"4","author":"Tirado-Rives","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2026.118704_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134782","article-title":"Synthesis, single crystal X-ray, DFT, spectroscopic, molecular docking studies and in vitro biological evaluation of compound N-benzyl-4-(4-chlorophenyl)-2-oxobutanamide","volume":"1276","author":"Das","year":"2023","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2026.118704_bb0325","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/acschemneuro.3c00245","article-title":"Design, synthesis, and biological evaluation of piperazine and N-benzylpiperidine hybrids of 5-phenyl-1,3,4-oxadiazol-2-thiol as potential multitargeted ligands for Alzheimer\u2019s disease therapy","volume":"14","author":"Waiker","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118704_bb0330","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1021\/acs.jmedchem.6b00636","article-title":"Development of multifunctional Pyrimidinylthiourea derivatives as potential anti-Alzheimer agents","volume":"59","author":"Li","year":"2016","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:18:46Z","timestamp":1783192726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626001604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"alternative-id":["S0968089626001604"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118704","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of novel multifunctional caffeic acid-piperazine derivatives for the management of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118704"}}